On the contrary, inhibition of ERK1/2 was proved to suppress tumor cell epithelial-mesenchymal transition (EMT) and induce apoptosis in ovarian cancer cells (Shi et al., 2020). This evidence concerns the gene MAPK3 and ovarian cancer.